Genomics of Drug Sensitivity in Cancer |
Pazopanib
|
Synonyms |
Votrient
|
Targets |
CSF1R, KIT, PDGFRA, PDGFRB
|
Target pathway |
RTK signaling
|
PubCHEM ID |
10113978
|
Jsmol |
|
Download molecule |
10113978
|
PUBCHEM IUPAC INCHI |
InChI=1S/C21H23N7O2S/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25)
|
Smiles |
S(=O)(=O)(N)C1(=C(C=CC(=C1)NC4(=NC(N(C3(=CC2(=NN(C)C(=C2C=C3)C)))C)=CC=N4))C)
|
Cluster number |
87
|
calculated LogS |
-5,921
|
Molecular weight |
437,527
|
calculated LogP |
1,7881
|
H-Acceptors |
9
|
H-Donors |
2
|
Ro5 violations |
0
|
Druglikeness |
3,5212
|
DrugScore |
0,187659322787565
|
Mutagenic |
high
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
high
|
Fish Toxicity |
Low FHMT
|
Fish Toxicity2 |
1,7277
|
Rat Acute Toxicity |
2,3961
|
Acute Oral Toxicity |
III
|
Caco-2 Permeability |
Caco2+
|
Caco-2 Permeability2 |
0,9553
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor2 |
Inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity2 |
0,3898
|
AMES Toxicity |
Non AMES toxic
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogenicity (Three-class) |
Non-carcinogens
|
Carcinogens |
Non-required
|
Blood-Brain Barrier |
BBB+
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
Low HBT
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Subcellular localization |
Lysosome
|
Human Intestinal Absorption |
HIA+
|
Aqueous solubility |
-2,8918
|